home / stock / cyrxw / cyrxw quote
Last: | $21.11 |
---|---|
Change Percent: | 0.0% |
Open: | $21.11 |
Close: | $21.11 |
High: | $21.11 |
Low: | $21.11 |
Volume: | 889 |
Last Trade Date Time: | 07/29/2020 04:55:30 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.11 | $21.11 | $21.11 | $21.11 | $21.11 | 889 | 07-29-2020 |
$30.3 | $30.3 | $30.3 | $30.3 | $30.29 | 913 | 07-17-2020 |
$30 | $28.8 | $30 | $30 | $28.75 | 856 | 07-15-2020 |
$29.13 | $29.13 | $29.13 | $29.13 | $29.13 | 493 | 07-14-2020 |
$29.8 | $29.8 | $29.8 | $29.8 | $29.8 | 250 | 07-13-2020 |
$30.34 | $30.41 | $30.34 | $30.41 | $30.34 | 1,500 | 07-10-2020 |
$29.92 | $30.12 | $29.92 | $30.12 | $29.92 | 2,624 | 07-09-2020 |
$29.36 | $29.36 | $29.36 | $29.36 | $29.36 | 142 | 07-08-2020 |
$28.7 | $28.58 | $28.7 | $28.7 | $28.58 | 210 | 07-03-2020 |
$28.7 | $28.58 | $28.7 | $28.7 | $28.58 | 210 | 07-02-2020 |
$27.9133 | $27.692 | $27.9133 | $28.3537 | $27.692 | 1,305 | 07-01-2020 |
$26.55 | $26.21 | $26.55 | $26.55 | $26.21 | 1,000 | 06-30-2020 |
$26.01 | $25.87 | $26.01 | $26.21 | $25.87 | 1,278 | 06-25-2020 |
$25.35 | $25.56 | $25.35 | $25.56 | $25.35 | 400 | 06-24-2020 |
$25.6 | $25.74 | $25.6 | $25.8687 | $25.6 | 775 | 06-23-2020 |
$24.78 | $24.37 | $24.78 | $24.78 | $24.37 | 8,431 | 06-22-2020 |
$24 | $23.38 | $24 | $24 | $23.38 | 2,200 | 06-19-2020 |
$23.58 | $23.58 | $23.58 | $23.58 | $23.58 | 1,000 | 06-18-2020 |
$23 | $22.99 | $23 | $23.04 | $22.5 | 8,207 | 06-16-2020 |
$22.11 | $22.5 | $22.11 | $22.5 | $22.1 | 3,900 | 06-15-2020 |
News, Short Squeeze, Breakout and More Instantly...
CryoPort Inc. Warrants Company Name:
CYRXW Stock Symbol:
NASDAQ Market:
PHILADELPHIA and OXFORDSHIRE, United Kingdom and IRVINE, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, and Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperatur...
SAN FRANCISCO and IRVINE, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Vineti, Inc. , and Cryoport , Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) announced a commercial partnership designed to extend end-to-end delivery of cell therapies and gene therapies to a growing number of patients as ...